Sort
326,823 grants matching “clinical trial”
Predicting Response to Standardized Pediatric Colitis Therapy: PROTECT Study
$2,684,971Jeffrey Samuel Hyams · Connecticut Children'S Medical Center · U01 · FY2012 · DK
Immune Modulation After Allogeneic HCT
$2,684,637Robert Jon Soiffer · Dana-Farber Cancer Inst · P01 · FY2022 · CA
Immune Modulation After Allogeneic HCT
$2,684,637Robert Jon Soiffer · Dana-Farber Cancer Inst · P01 · FY2023 · CA
Cochlear Synaptopathy: Prevalence, Diagnosis and Functional Consequences
$2,684,344Sharon Kujawa · Massachusetts Eye And Ear Infirmary · P50 · FY2023 · DC
Cochlear Synaptopathy: Prevalence, Diagnosis and Functional Consequences
$2,684,343Sharon Kujawa · Massachusetts Eye And Ear Infirmary · P50 · FY2025 · DC
Cochlear Synaptopathy: Prevalence, Diagnosis and Functional Consequences
$2,684,343Sharon Kujawa · Massachusetts Eye And Ear Infirmary · P50 · FY2024 · DC
Preventive Vaccines for HIV
$2,684,061Genoveffa Franchini · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Establishment of a Human Microphysiological System to Elucidate Cellular Mechanisms Underlying Vulnerability to AD
$2,683,965Tracy L Young-Pearse · Brigham And Women'S Hospital · RF1 · FY2025 · NS
CoVPN 3005 - Efficacy, Immunogenicity, and Safety of SARS-CoV-2 Recombinant Protein Vaccine with Adjuvant in Adults 18 Years of Age and Older
$2,683,830Lawrence Corey · Fred Hutchinson Cancer Center · UM1 · FY2023 · AI
Barrier Damage and The Immune CascadeNorthwestern University CounterACT Center of Excellence (NUCCX)
$2,683,799Kurt Lu · Northwestern University At Chicago · U54 · FY2023 · AR
Bone Marrow Grafting for Leukemia and Lymphoma
$2,683,519Stanford University · P01 · FY2003 · CA
Organized Lipid Matrix: Fatty Acids and Choline in Cystic Fibrosis
$2,682,829Walter A Shaw · Avanti Polar Lipids, Inc. · R44 · FY2007 · DK
CLINICAL STUDIES MANAGEMENT AND SUPPORT (CSMS) - SOLE SOURCE BRIDGE CONTRACT
$2,682,814Huiqing You · Kai Research, Inc · N02 · FY2023 · HL
Advanced Fibrosis Detection and a Predictive Diagnostic Model for Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) in Primary Care
$2,682,628Andrew David Schreiner · Medical University Of South Carolina · R01 · FY2025 · DK
The University of Rochester Clinical and Translational Science Award Hub
$2,681,566Martin S Zand · University Of Rochester · UL1 · FY2023 · TR
A Unified Clinical Genomics Database
$2,681,249Heidi L Rehm · Brigham And Women'S Hospital · U41 · FY2015 · HG
National Lung Screening Trial
$2,681,213Barbara B O'Brien · Westat, Inc. · N01 · FY2010 · CA
SPORE IN PROSTATE CANCER
$2,680,997William George Nelson · Johns Hopkins University · P50 · FY2006 · CA
Understanding and Overcoming T cell Immunosuppression in Glioblastoma
$2,680,832E. Antonio Chiocca · Brigham And Women'S Hospital · P01 · FY2024 · CA
Bone Marrow Grafting and Cellular Therapy for Leukemia and Lymphoma
$2,680,780Robert S Negrin · Stanford University · P01 · FY2022 · CA
Upper Gastrointestinal Cancer Studies
$2,680,713Sanford M Dawsey · Division Of Cancer Epidemiology And Genetics · ZIA · FY2022 · CA
Safety/Tolerability/Immunogenicity of first-in-human Aβ DNA vaccine, AV-1959D Phase 1 trials in early-stage AD subjects: based on IND18953 cleared by FDA.
$2,680,709Michael G Agadjanyan · Institute For Molecular Medicine · R01 · FY2022 · AG
Chemoprophylaxis for HIV Prevention in Men
$2,680,398Robert M. Grant · J. David Gladstone Institutes · U01 · FY2007 · AI
Metro-Minnesota Community Clinical Oncology Program (MM-CCOP)
$2,680,381Daniel M Anderson · Healthpartners Institute · UG1 · FY2017 · CA
Development of PPL-138, a Novel Mixed NOP/Mu Partial Agonist for Treatment of CocaineUse Disorder
$2,680,161Lawrence R Toll · Phoenix Pharmalabs, Inc. · U01 · FY2022 · DA